AstraZeneca enters agreement with Pfizer for OTC NEXIUM Pfizer Inc.

Tony Zook Executive Vice President of AstraZeneca’s Global Industrial Organisation said, AstraZeneca is definitely a head in the gastrointestinal sector, and we think that an OTC edition of NEXIUM will complement this globally successful prescription drugs and help bring relief to even more patients all over the world. We’re very happy to work with Pfizer Consumer Health care and believe their advertising and sales of consumer health items makes them the perfect partner to commercialise OTC NEXIUM globally. This agreement can help AstraZeneca realize the substantial, long-term value of the brand and additional brands potentially inside our portfolio.Attempts elsewhere in the united states have already been hampered by shortages of gear, infrastructure and funds. The H5N1 avian influenza virus offers spread in birds at a fantastic rate lately, sweeping through elements of Europe, into Africa and surfacing once again in Asia. The virus offers killed at least 109 people since 2003 worldwide, which is definitely but a fraction of the deaths predicted if the virus mutates and spreads quickly from individual to individual.. Bioniche receives U.S. And Canadian authorization for to begin two canine oncology products Bioniche Existence Sciences Inc. , a research-based, technology-driven Canadian biopharmaceutical company, today announced that the to begin two canine oncology items has received authorization by regulators in both U.S.

Random entries

Other entries from category "angiology":